OCOcean E. Clarke

Ocean E. Clarke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ocean E. Clarke has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A poly(trisulfide) prodrug with antimicrobial activity

    by Jasmine Pople, Ocean Clarke, Romy Dop, Thomas Nicholls, Harshal Patel, Witold Bloch, Zhongfan Jia, Sara Fraser-Miller, Evangeline Cowell, Jillian Carr, et al.

    Antimicrobial resistance is a growing threat to human health and agriculture. Sulfur-containing compounds and elemental sulfur have a long history of use as antimicrobials, but challenges related to solubility and formulation have limited their broad application. Recent advances in sulfur polymer chemistry have enabled the development of novel sulfur-rich materials with antimicrobial activity. However, most of these materials are water-insoluble, limiting their use in biomedical and agricultural applications. Here, we report the synthesis of a linear poly(trisulfide) via photochemical ring-opening polymerization of a cyclic trisulfide monomer bearing a carboxylic acid. Deprotonation of the carboxylic acid renders the poly(trisulfide) fully water soluble, with concomitant chain scission via S-S cleavage. The resulting poly(trisulfide) oligomers exhibited potent antifungal activity against Candida albicans (MIC < 8 µg/mL), and stronger inhibition of the Gram-positive bacterium Staphylococcus aureus (MIC = 16 µg/mL) compared to the Gram-negative Escherichia coli (MIC > 512 µg/mL). In control experiments, the monomer did not show potent antifungal or antibacterial activity. This work demonstrates a simple and controllable synthesis of a poly(trisulfide) species that serves as a prodrug: treatment with NaOH converts the polymer to water-soluble oligomers with antimicrobial activity. This approach is a new direction for biological applications of sulfur polymers and a new strategy to address antimicrobial resistance.

  • Open Access

    Prevalence of mutations associated with tolerance to chlorhexidine and other cationic biocides among Proteus mirabilis clinical isolates

    by Vicky Bennett, Ocean E. Clarke, Maryam Y. Ravari, James D. Winslow, Matthew E. Wand, Andrew Preston, Emma L. Denham, J. Mark Sutton, Brian V. Jones

    Proteus mirabilis is a frequent cause of catheter-associated urinary tract infection and often exhibits high tolerance to chlorhexidine (CHD), a biocide used widely in healthcare settings. We previously demonstrated that inactivation of the smvR repressor (leading to overexpression of the smvA efflux system), truncation of the MltA-interacting protein MipA and aspects of lipopolysaccharide (LPS) structure modulate CHD susceptibility in this organism. However, the prevalence of these mechanisms among P. mirabilis clinical isolates, the conditions under which they can be acquired and their impact on susceptibility to other cationic biocides require further study. Through phenotypic and genomic analysis of a panel of 78 P. mirabilis clinical isolates, we have confirmed that deleterious mutations in smvR commonly arise in P. mirabilis and are significantly associated with reduced susceptibility to CHD and other cationic biocides. Mutations in mipA were also associated with CHD tolerance. Conversely, mutations in smvA and the rppA response regulator (which governs lipid A modifications that alter LPS surface charge) were associated with increased susceptibility to several biocides. Several isolates harbouring smvR mutations displayed incongruous phenotypes, exhibiting relatively modest CHD tolerance, which could not be accounted for by co-occurring mutations in smvA and rppA or defects in LPS (as assessed by polymyxin B susceptibility). Further analysis of these isolates revealed mutations in the LPS core biosynthesis gene waaG, leading to LPS truncation from the inner core region. Directed evolution experiments further reinforced the importance of smvR inactivation in biocide adaptation in P. mirabilis and demonstrated that relevant mutations can be selected for by exposure to CHD concentrations up to four times lower than the minimum inhibitory concentration. Taken together, these results expand our understanding of mechanisms underlying tolerance to cationic biocides in this species and provide evidence for common mechanisms of cationic biocide tolerance.


  • An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

    by Ocean E. Clarke, Vicky Bennett, Brian V. Jones

    Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Biofilm formation on urinary catheters is a key aspect in the pathogenesis of these infections, and frequently leads to blockage of catheters and serious complications such as pyelonephritis and septicaemia. Approaches to model and study biofilm formation in this setting are essential for both a fundamental understanding of the mechanisms underpinning the pathogenesis of CAUTI, as well as the development and robust pre-clinical evaluation of effective therapeutic strategies to control CAUTI and catheter blockage. This protocol describes an in vitro model of the catheterized urinary tract, which replicates the catheter closed drainage system as used in clinical practice, facilitating the study of CAUTI and catheter biofilm formation under representative conditions. Furthermore, this protocol details the application of the in vitro bladder model to evaluate the efficacy of antimicrobial catheter maintenance products, including products currently available on the NHS supply chain.


  • JoVE Video Dataset

    by Ocean E. Clarke, Vicky Bennett, Brian V. Jones

    Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Biofilm formation on urinary catheters is a key aspect in the pathogenesis of these infections, and frequently leads to blockage of catheters and serious complications such as pyelonephritis and septicaemia. Approaches to model and study biofilm formation in this setting are essential for both a fundamental understanding of the mechanisms underpinning the pathogenesis of CAUTI, as well as the development and robust pre-clinical evaluation of effective therapeutic strategies to control CAUTI and catheter blockage. This protocol describes an in vitro model of the catheterized urinary tract, which replicates the catheter closed drainage system as used in clinical practice, facilitating the study of CAUTI and catheter biofilm formation under representative conditions. Furthermore, this protocol details the application of the in vitro bladder model to evaluate the efficacy of antimicrobial catheter maintenance products, including products currently available on the NHS supply chain.